MULTIFOCAL LEUKOENCEPHALOPATHY - OCCURRENCE DURING 5-FLUOROURACIL AND LEVAMISOLE THERAPY AND RESOLUTION AFTER DISCONTINUATION OF CHEMOTHERAPY

被引：33
|
作者：
KIMMEL, DW [1 ]
SCHUTT, AJ [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
来源：
MAYO CLINIC PROCEEDINGS | 1993年 / 68卷 / 04期
关键词：
D O I：
10.1016/S0025-6196(12)60132-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report the fourth case of cerebral demyelinating disease associated with 5-fluorouracil and levamisole hydrochloride therapy for adenocarcinoma of the colon. The initial manifestations included subacute progressive decline in mental status, ataxia, dysarthria, and diplopia. Magnetic resonance imaging of the head demonstrated multifocal enhanced lesions in the white matter. The patient experienced improvement, without corticosteroid treatment, from 2 weeks to 4 months after cessation of chemotherapy.
引用
收藏
页码：363 / 365
页数：3
相关论文
共 50 条
  • [31] ACUTE MYOCARDIOTOXICITY DURING 5-FLUOROURACIL THERAPY
    MISSET, B
    ESCUDIER, B
    LECLERCQ, B
    RIVARA, D
    ROUGIER, P
    NITENBERG, G
    [J]. INTENSIVE CARE MEDICINE, 1990, 16 (03) : 210 - 211
  • [32] Acute hyperammonemic encephalopathy after 5-fluorouracil based chemotherapy
    Yi, Hee Jung
    Hong, Kyung Sook
    Moon, Nara
    Chung, Soon Sup
    Lee, Ryung-Ah
    Kim, Kwang Ho
    [J]. ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2016, 90 (03) : 179 - 182
  • [33] Sclerosing canaliculitis after 5-fluorouracil breast cancer chemotherapy
    Vickie Lee
    Christopher R Bentley
    Jane M Olver
    [J]. Eye, 1998, 12 : 343 - 349
  • [34] Sclerosing canaliculitis after 5-fluorouracil breast cancer chemotherapy
    Lee, V
    Bentley, CR
    Olver, JM
    [J]. EYE, 1998, 12 (3) : 343 - 349
  • [35] Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma
    Witte, RS
    Cnaan, A
    Mansour, EG
    Barylak, E
    Harris, JE
    Schutt, AJ
    [J]. CANCER, 2001, 91 (05) : 1020 - 1028
  • [36] HOST-TUMOR INTERACTION DURING 5-FLUOROURACIL CHEMOTHERAPY
    DECOSSE, JJ
    ZUIK, M
    MANDEL, MA
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1971, 12 (NMAR): : 50 - &
  • [37] PROTECTION OF MICE WITH HEMOBLASTOSIS BY ALLOPURINOL DURING CHEMOTHERAPY WITH 5-FLUOROURACIL
    BUKHMAN, VM
    MAMEDOV, FF
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1983, 96 (08) : 1131 - 1134
  • [38] INFLAMMATORY LEUKOENCEPHALOPATHY CAUSED BY ADJUVANT THERAPY WITH 5-FLUOROURACIL AND LEVAMISOL FOR COLON-CARCINOMA
    FERROIR, JP
    FENELON, G
    BEAUGERIE, L
    RECOING, DA
    [J]. REVUE NEUROLOGIQUE, 1994, 150 (6-7) : 471 - 474
  • [39] DISABLING ENCEPHALOPATHY DURING 5-FLUOROURACIL AND LEVAMISOLE ADJUVANT THERAPY FOR RESECTED COLORECTAL-CANCER - A REPORT OF 2 CASES
    FIGUEREDO, AT
    FAWCET, SE
    MOLLOY, DW
    DOBRANOWSKI, J
    PAULSETH, JE
    [J]. CANCER INVESTIGATION, 1995, 13 (06) : 608 - 611
  • [40] Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy
    Alireza Mafi
    Malihe Rezaee
    Neda Hedayati
    Sara Diana Hogan
    Russel J. Reiter
    Mohammad-Hossein Aarabi
    Zatollah Asemi
    [J]. Cell Communication and Signaling, 21
12345